242
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Safety and Outcome of Microincision Vitreous Surgery in Uveitis

, MS, , MS, , MS, , MS, , MS, , MS, , MS, , MD, , MD, , MD, , PhD & , MSc show all
Pages 775-784 | Received 11 Dec 2015, Accepted 07 Mar 2016, Published online: 18 May 2016

REFERENCES

  • Diamond JG, Kaplan HJ. Uveitis: effect of vitrectomy combined with lensectomy. Ophthalmology. 1979;86:1320–1329.
  • Becker M, Davis J. Vitrectomy in the treatment of uveitis. Am J Ophthalmol. 2005;140:1096–1105.
  • Kitiratschky VBD, Deuter C, Beck R, et al. Relationship between suspected reasons of intraocular inflammation and the results of diagnostic vitrectomy: an observational study. Ocul Immunol Inflamm. 2015;23:59–66.
  • Oahalou A, Schellekens PAWJF, De Groot-Mijnes JD, et al. Diagnostic pars plana vitrectomy and aqueous analyses in patients with uveitis of unknown cause. Retina. 2014;34:108–114.
  • Foster CS, Opremcak EM. Therapeutic surgery: cornea, iris, cataract, glaucoma, vitreous, retinal. In: Foster CS, Vitale A, eds. Diagnosis and Treatment of Uveitis. Philadelphia, PA: WB Saunders; 2002:222–235.
  • Androudi S, Praidou A, Symeonidis C, et al. Safety and efficacy of small incision, sutureless pars plana vitrectomy for patients with posterior segment complications secondary to uveitis. Acta Ophthalmol. 2012;e409–e410.
  • Takayama K, Tanaka A, Shibata M, et al. Evaluation of microincision vitrectomy surgery using a wide-viewing system for complications with ocular sarcoidosis. Medicine. 2015;94:e559.
  • Soheilian M, Ramezani A, Soheilian R. 25-gauge vitrectomy for complicated chronic endogenous/autoimmune uveitis: predictors of outcomes. Ocul Immunol Inflamm. 2013;21:93–101.
  • Bansal R, Sharma K, Gupta A, et al. Detection of Mycobacterium tuberculosis genome in the vitreous fluid of eyes with multifocal serpiginoid choroiditis. Ophthalmology. 2015;122:840–850.
  • Nussenblatt RB, Palestine AG, Chan CC, et al. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92:467–471.
  • Esterberg E, Acharya NR. Corticosteroid-sparing therapy: practice patterns among uveitis specialists. J Ophthalmic Inflamm Infect. 2012;2:21–28.
  • Bamonte G, Mura M, Stevie Tan H. Hypotony after 25-G vitrectomy. Am J Ophthalmol. 2011;151:156–160.
  • Rizzo S, Genovesi-Ebert F, Murri S, et al. 25-gauge, sutureless vitrectomy and standard 20-gauge pars plana vitrectomy in idiopathic epiretinal membrane surgery: a comparative pilot study. Graefes Arch Clin Exp Ophthalmol. 2006;244:472–479.
  • Kobayashi S, Sato S, Inoue M, et al. Comparison of 20- and 25-gauge vitrectomy for primary repair of rhegmatogenous retinal detachment. Ophthalmic Surg Lasers Imaging. 2010;41:550–554.
  • Kiryu J, Kita M, Tanabe T, et al. Pars plana vitrectomy for epiretinal membrane associated with sarcoidosis. Jpn J Ophthalmol. 2003;47:479–483.
  • Sato T, Emi K, Bando H, et al. Faster recovery after 25-gauge microincision vitrectomy surgery than after 20-gauge vitrectomy in patients with proliferative diabetic retinopathy. Clin Ophthalmol. 2012;6:1925–1930.
  • Quinones K, Choi JY, Yilmaz T, et al. Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study. Ocul Immunol Inflamm. 2010;18:411–417.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.